NCT00992472View on ClinicalTrials.gov

Bioavailability of Prochlorperazine Suppositories, 25 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

Not specified

Conditions
Healthy
Interventions
DRUG

Prochlorperazine suppositories, 25mg

DRUG

Compazine® suppositories, 25mg

Trial Locations (1)

21201

PharmaKinetics Laboratories, Inc, Baltimore

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY

NCT00992472 - Bioavailability of Prochlorperazine Suppositories, 25 mg | Biotech Hunter | Biotech Hunter